185750 — Chong Kun Dang Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩1tn
- KR₩981bn
- KR₩2tn
- 76
- 62
- 14
- 51
Annual cashflow statement for Chong Kun Dang Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 90,405 | 42,356 | 79,978 | 213,602 | 111,442 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 61,870 | 68,893 | 51,538 | 52,783 | 19,135 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -71,737 | -125,827 | -97,379 | 14,745 | -106,060 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 104,324 | 12,904 | 67,734 | 318,160 | 64,289 |
| Capital Expenditures | -36,818 | -51,844 | -53,065 | -68,806 | -66,102 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -27,103 | -38,965 | -12,316 | -102,507 | 69,833 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -63,921 | -90,809 | -65,380 | -171,313 | 3,731 |
| Financing Cash Flow Items | — | — | — | -16.5 | -29.7 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7,069 | 85,139 | -16,340 | -43,700 | -63,112 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 46,737 | 8,154 | -14,396 | 102,229 | 8,824 |